GlassScriptPhysician profile
Patrick L Hughes
NPI 1598790909
$4,449.95
in general payments reported to CMS, 2019-2025
23 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $961 · 2020: $1,057 · 2021: $1,355 · 2022: $1,077.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $722.22 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $681.32 | 2019-2022 | |
| Lundbeck LLC | $667.62 | 2019-2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $503.85 | 2020-2022 | |
| Abbvie INC. | $377.08 | 2021-2022 | |
| Teva Pharmaceuticals USA, INC. | $338.87 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $257.97 | 2019-2022 | |
| Vanda Pharmaceuticals INC. | $184.36 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $139.54 | 2019-2022 | |
| Bausch Health US, LLC | $91.77 | 2020-2022 | |
| Allergan, INC. | $88.84 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $73.74 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $61.56 | 2019-2020 | |
| Almatica Pharma LLC | $47.30 | 2021-2022 | |
| Tris Pharma INC | $29.82 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $28.79 | 2022 | |
| Adlon Therapeutics L.P. | $27.95 | 2019 | |
| Shire North American Group INC | $26.23 | 2019 | |
| Alkermes, INC. | $24.68 | 2022 | |
| Eisai INC. | $23.87 | 2020 | |
| Axsome Therapeutics, INC. | $20.04 | 2022 | |
| Supernus Pharmaceuticals, INC. | $19.22 | 2022 | |
| Jazz Pharmaceuticals INC. | $13.31 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Hughes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.